Cargando…
Costs and Treatment Pathways for Type 2 Diabetes in the UK: A Mastermind Cohort Study
INTRODUCTION: Medication therapy for type 2 diabetes has become increasingly complex, and there are few reliable data on the current state of clinical practice. We report treatment pathways and associated costs of medication therapy for people with type 2 diabetes in the UK, their variability and ch...
Autores principales: | Eibich, Peter, Green, Amelia, Hattersley, Andrew T., Jennison, Christopher, Lonergan, Mike, Pearson, Ewan R., Gray, Alastair M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5630552/ https://www.ncbi.nlm.nih.gov/pubmed/28879529 http://dx.doi.org/10.1007/s13300-017-0296-x |
Ejemplares similares
-
Risk of Anemia With Metformin Use in Type 2 Diabetes: A MASTERMIND Study
por: Donnelly, Louise A., et al.
Publicado: (2020) -
What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
por: McGovern, Andrew P., et al.
Publicado: (2019) -
TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
por: Angwin, Catherine, et al.
Publicado: (2020) -
Cohort profile for the MASTERMIND study: using the Clinical Practice Research Datalink (CPRD) to investigate stratification of response to treatment in patients with type 2 diabetes
por: Rodgers, Lauren R, et al.
Publicado: (2017) -
Midsummer mysteries: Criminal masterminds? Not really…
por: Antonella Del Rosso
Publicado: (2014)